257 related articles for article (PubMed ID: 28403890)
21. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
22. Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.
Pettke A; Hotfilder M; Clemens D; Klco-Brosius S; Schaefer C; Potratz J; Dirksen U
Anticancer Drugs; 2016 Nov; 27(10):1001-10. PubMed ID: 27487911
[TBL] [Abstract][Full Text] [Related]
23. Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway.
Guo Y; Huang C; Li G; Chen T; Li J; Huang Z
Mol Med Rep; 2015 Sep; 12(3):3681-3687. PubMed ID: 26017247
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of quercetin as a potential drug in osteosarcoma treatment.
Berndt K; Campanile C; Muff R; Strehler E; Born W; Fuchs B
Anticancer Res; 2013 Apr; 33(4):1297-306. PubMed ID: 23564766
[TBL] [Abstract][Full Text] [Related]
25. Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells.
Wang G; Chen S; Edwards H; Cui X; Cui L; Ge Y
Oncol Rep; 2014 Dec; 32(6):2789-94. PubMed ID: 25333301
[TBL] [Abstract][Full Text] [Related]
26. BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.
Gobin B; Huin MB; Lamoureux F; Ory B; Charrier C; Lanel R; Battaglia S; Redini F; Lezot F; Blanchard F; Heymann D
Int J Cancer; 2015 Feb; 136(4):784-96. PubMed ID: 24961790
[TBL] [Abstract][Full Text] [Related]
27. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
[TBL] [Abstract][Full Text] [Related]
28. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells.
Naruse T; Nishida Y; Ishiguro N
Biomed Pharmacother; 2007 Jul; 61(6):338-46. PubMed ID: 17395421
[TBL] [Abstract][Full Text] [Related]
30. The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.
Wilke NL; Abodo LO; Frias C; Frias J; Baas J; Jakupec MA; Keppler BK; Prokop A
Biomed Pharmacother; 2022 Dec; 156():113974. PubMed ID: 36411649
[TBL] [Abstract][Full Text] [Related]
31. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
32. Antimetastatic activity of honokiol in osteosarcoma.
Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic effects of delphinidin in human osteosarcoma cells.
Lee DY; Park YJ; Hwang SC; Kim KD; Moon DK; Kim DH
Acta Orthop Traumatol Turc; 2018 Jan; 52(1):58-64. PubMed ID: 29290536
[TBL] [Abstract][Full Text] [Related]
34. 7-hydroxy-staurosporine, UCN-01, induces DNA damage response, and autophagy in human osteosarcoma U2-OS cells.
Lien WC; Chen TY; Sheu SY; Lin TC; Kang FC; Yu CH; Kuan TS; Huang BM; Wang CY
J Cell Biochem; 2018 Jun; 119(6):4729-4741. PubMed ID: 29280173
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
Zhang W; Li Q; Song C; Lao L
Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
[TBL] [Abstract][Full Text] [Related]
36. Chloroquine and valproic acid combined treatment in vitro has enhanced cytotoxicity in an osteosarcoma cell line.
Wang CK; Yu XD; Li Q; Xie G; Teng Y
Asian Pac J Cancer Prev; 2013; 14(8):4651-4. PubMed ID: 24083719
[TBL] [Abstract][Full Text] [Related]
37. Marrubenol inhibits osteosarcoma cancer cell growth by inducing autophagic cell death and inhibiting cancer cell migration and invasion.
Zhang Y; Ma R; Cheng S; Gu G
J BUON; 2018; 23(3):729-734. PubMed ID: 30003743
[TBL] [Abstract][Full Text] [Related]
38. Anticancer activity of Germacrone terpenoid in human osteosarcoma cells is mediated via autophagy induction, cell cycle disruption, downregulating the cell cycle regulatory protein expressions and cell migration inhibition.
Li E; Gao Y; Mou L; Zhang Z
Acta Biochim Pol; 2022 Apr; 69(2):305-308. PubMed ID: 35468267
[TBL] [Abstract][Full Text] [Related]
39. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
40. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Ma K; Zhang C; Huang MY; Li WY; Hu GQ
Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
